Related content

Triggering ovulation with 250 μg or 500 μg of r-hCG in oocyte donors treated with antagonist protocol has no effect on the number of mature oocytes retrieved: a randomized clinical trial

By Clua Elisabet   Martínez Francisca   Tur Rosa   Sanmartín Paula   Chueca Ana   Barri Pere N.  

Gynecological Endocrinology, Vol. 28, Iss. 9, 2012-09 ,pp. : 678-681

Informa Healthcare

Access to resources Recommend Favorite

Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial

By Lossl K.   Andersen C. Yding   Loft A.   Freiesleben N.L.C.   Bangsbll S.   Andersen A. Nyboe  

Human Reproduction, Vol. 23, Iss. 8, 2008-08 ,pp. : 1820-1829

Oxford University Press

Access to resources Recommend Favorite

Timing of human chorionic gonadotrophin (hCG) hormone administration in IVF protocols using GnRH antagonists: a randomized controlled trial

By Morley L.  

Human Fertility, Vol. 15, Iss. 3, 2012-09 ,pp. : 134-139

Informa Healthcare

Access to resources Recommend Favorite

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Humaidan P.  

Human Reproduction, Vol. 20, Iss. 5, 2005-05 ,pp. : 1213-1220

Oxford University Press

Access to resources Recommend Favorite

Reply: GnRH agonist (buserelin) or hCG for ovulation induction in gnRH antagonist IVF/ICSI cycles: a prospective randomized study

By Humaidan Peter  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3260-3260

Oxford University Press

Access to resources Recommend Favorite